Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Gilead Sciences Stock: Is Wall Street Bullish or Bearish?

With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines. Based in Foster City, California, the company is renowned for its focus on treating serious diseases, particularly in the areas of HIV/AIDS, liver diseases, oncology, and inflammatory conditions.

Shares of GILD have outperformed the broader market over the past year. The stock has gained 23.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.7%. In 2025, GILD is up 5.2% compared to SPX’s 2.7% rise on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.